Navigation Links
Higher incidence of bile duct injury during laparoscopic cholecystectomy

Laparoscopic cholecystectomy (LC) has rapidly substituted traditional cholecystectomy, and represents the gold standard for surgical treatment of cholelithiasis. Bile duct injury (BDI) remains the most serious //complication of cholecystectomy. According to a recent survey, published in the October issue of the journal Archives of Surgery, the incidence of BDI has become more frequent with LC. The study verifies the current incidence, mechanism, presentation, and treatment of BDI occurring during LC in general surgical practice. The authors report the results of a recently performed multicenter national survey to provide an up-to-date assessment of the rate, causes, clinical manifestations, and treatment of BDI in 56, 591 patients who underwent LC between January 1, 1998, and December 31, 2000, in 184 hospitals in Italy. Out of these, 235 BDIs were reported, with an overall incidence of 0.42%. There were no risk factors in 80.0% of the patients.

Poor identification of the anatomical features of the hepatic pedicle was the most frequently reported cause (36.8%), and technical problems accounted for 27.0% of causes. The incidence of BDI was higher during cholecystitis (P<.001) and decreased with increasing number of LCs performed by the surgical teams (P<.01). There was no difference in incidence according to technique (French or US) or to routine or selective intraoperative cholangiography.

One hundred eight BDIs (46.0%) were recognized intraoperatively and immediately repaired in 89.8% of patients. One hundred twenty-seven BDIs (54.0%) were diagnosed postoperatively, the dominant manifestation being biliary fistula (44.1%).

This study confirms a higher incidence of BDI during LC. It highlights the relevance of the number of previously performed LCs and of the correct surgical technique to avoid BDI. The need for correct procedures, adequate expertise of the repairing surgeon in BDI repairs, and a multidisciplinary approach in the man agement of BDI is emphasized.

Related medicine news :

1. Higher Risk of Asthma in children with autoimmune disease
2. Death Risk Higher in Obese Women with Colon Cancer
3. Women With Diabetes Have a Higher Risk of Depression
4. Individuals Born In May At A Higher Risk Of Developing Multiple Sclerosis
5. Higher Statin Dose Safely Reduces Stroke and Cardiac Arrest
6. Premature Babies More Likely If Women Have Higher Protein Albumin In Urine
7. HIV Infection Higher In Drug Trafficking Countries
8. Math Learning Disorder Higher in Boys
9. Math Learning Disorder Higher In Boys
10. Tall Children Have An Higher IQ
11. Higher Rates Of Diabetes Found Among The Poor
Post Your Comments:

(Date:10/12/2017)... CA (PRWEB) , ... October 12, 2017 , ... ... Cheng, are now treating sleep apnea using cutting-edge Oventus O2Vent technology. ... a serious sleep disorder characterized by frequent cessation in breathing. Oral appliances can ...
(Date:10/12/2017)... ... October 12, 2017 , ... The company has developed ... consumer and regulatory authorities worldwide. From Children’s to Adults 50+, every formula has ... highest standard. , These products are also: Gluten Free, Non-GMO, Vegan, Soy ...
(Date:10/12/2017)... ... 12, 2017 , ... The American College of Medical Informatics (ACMI) will present ... the Opening Session of AMIA’s Annual Symposium in Washington, D.C. AMIA’s Annual Symposium ... Collen, a pioneer in the field of medical informatics, this prestigious award is presented ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the technology: ... develop to enable prevention of a major side effect of chemotherapy in children. ... pediatric patients. For cisplatin, hearing loss is FDA listed on-label as a dose ...
(Date:10/12/2017)... Malvern, PA (PRWEB) , ... October 12, 2017 , ... ... is the recipient of a 2017 Folio Magazine Eddie Digital Award for ‘Best ... New York City on October 11, 2017. , The annual award competition recognizes editorial ...
Breaking Medicine News(10 mins):
(Date:9/23/2017)... HORSHAM, Pa. , Sept. 22, 2017 ... received a complete response letter from the U.S. Food ... (BLA) seeking approval of sirukumab for the treatment of ... response letter indicates additional clinical data are needed to ... of moderately to severely active RA. ...
(Date:9/19/2017)... Inc., a venture-backed medical device company developing a non-invasive, robotically assisted, platform therapy that uses ... today:   ... Jim ... Tom Tefft ... Veteran medical device executive Josh Stopek , PhD, who has led R&D and business ...
(Date:9/18/2017)... 2017 EpiVax, Inc. ("EpiVax") a ... immune engineering, today announced a new NIH-funded ... ... and presents a challenge for traditional flu ... be effective. Using state-of-the-art bioinformatics and molecular modeling methods, ...
Breaking Medicine Technology: